Skip to main content
PGEN logo

PGEN

Precigen Inc

$5.12

0.00%

Trade Ideas Performance

Latest Closed Trade Idea

$5.12

0.00%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

13

Social

49

About

Events of Precigen Inc (PGEN)

Over the past six months, Precigen's stock has been impacted by the FDA approval of PAPZIMEOS, robust uptake and revenue expectations, and the J-code assignment for PAPZIMEOS. Full year 2025 financial results and analyst bullishness also contributed positively. An announcement regarding Q1 2026 earnings led to selling pressure, while presentations and conferences helped reinforce the company's positioning. High insider ownership and positive insider trading signals have also buoyed the stock.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Precigen, Inc. (PGEN) Live Stock Price, Chart & Financial News | Edge Hound